Introduction
The advent of solid organ transplantation for the treatment of patients with end-stage organ failure has been one of the most exciting medical advances in the late 20th and early 21st centuries [1] . However, complications such as infection and allograft rejection were remaining major causes of morbidity and mortality. Epidemiologically, some viral infections are the result of community exposures (influenza, adenovirus), whereas some are commonly transmitted with the allograft (cytomegalovirus, 
Materials and methods
A cross sectional study was designed to estimate the prevalence 
Results
The results showed that the percentage of renal transplant patients was increased with increasing age, 71.05% of the patients were males, and most of them (56.57%) were living in cities. (Figure 1 ). Most of IgG positive patients had hypertension and atrophy diseases, whereas, IgM positive patient had atrophy disease (Table   2 ). About 75% of positive IgM cases were administrated prograf as an immunosuppressive drug, and 25% were administered cyclosporine. While in IgG positive cases, 83.92% were administrated prograf as an immunosuppressive drug, 13.29% were administered cyclosporine, and 2.79% were administrated prograf plus prednisolone drug (Figure 2) . Table 2 Association of clinical data with serological markers of Epstein-Barr virus. n (%). 
Discussion
Epstein-Barr virus has a significance effect among organ transplant recipients. Post-transplant lymphoproliferative disease, is a major complication among organ transplant recipients. In the present study we shown that 71.05% of the renal transplant patients were males, 56.57% were living in cities and the percentage of renal transplant patients was increased with increasing age. In Sudan the number of transplant patients was increase every year, and 85.53% of the patients had renal transplantation in Sudan.
Lauzurica et al. [13] [19] . Geramizadeh et al. [20] showed that 11/116 (9%) of patients were viral capsid antigen IgM positive. Epstein-Barr virus sero-prevalence in western societies can be as high as 95% among adult people [21] , in Turkey 99.4% were seropositivity [22] . Epstein-Barr virus seropositivity was increased with age in transplant population [23] . Previous studies recommend screening for Epstein-Barr virus DNA during the first year particularly for high risk Epstein-Barr virus donors, like sero-positive recipients and sero-negative patients [14] . High Epstein-Barr virus loads probably indicate a "net state of over immunosuppression" manifested as a reactivation of lytic EpsteinBarr virus infection [24] . Diseases associated with renal transplant patients were hypertension 18.42%, infectious diseases 7.24%, renal diseases 3.95%, atrophy 6.58%, gout 2.63% and other diseases 61.18%. Allain-Launay et al. [25] showed that 39.5% and 36.0% of the patients were treated for hypertension at five and ten years following transplantation [26, 27] . Most IgG positive patients have hypertension and atrophy diseases, whereas, IgM positive patient have atrophy disease. About 75% of IgM positive patients were administrated prograf and 25% cyclosporine as an immunosuppressive drug.
While 83.92% IgG positive patients were administrated prograf, 13.29% cyclosporine, and 2.79% prograf plus prednisolone as an immunosuppressive drug. Previous studies showed that major complication was associated with prograf based immunosupression [28] .
